Survival curves for a mouse cancer model. Mice receiving combined therapy with an immune checkpoing inhibitor against CTLA-4 and an antibodey that neutralizing sMIC survived. Mice receiving control or individual treatment did not. Figure 1A from Zhang et al., Sci Adv. 3 e1602133 (2017).